Despite the 17% correction from its recent highs, shares of Emcure Pharma are trading above their IPO price of ₹1,008. Previous Post Zen Technologies gains on securing patent for T-90 crew gunnery simulator Next Post NTPC Green Energy shares may see a subdued listing on Wednesday Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
